Hyperthermic nanomedicines are particularly relevant for tackling human cancer, providing
a valuable alternative to conventional therapeutics. The early-stage preclinical performance …

The ability to selectively destroy cancer cells while sparing normal tissue is highly desirable
during cancer therapy. Herein, dual-targeted photothermal therapy was achieved by the …

The use of magnetic nanoparticles in oncothermia has been investigated for decades, but
an effective combination of magnetic nanoparticles and localized chemotherapy under …

Magnetic hyperthermia-based cancer therapy (MHCT) has surfaced as one of the promising
techniques for inaccessible solid tumors. It involves generation of localized heat in the tumor …

Deliberate and local increase of the temperature within solid tumors represents an effective
therapeutic approach. Thermal therapies embrace this concept leveraging the capability of …

The deployment of hyperthermia‐based treatments for cancer therapy has captured the
attention of different researchers worldwide. In particular, the application of light‐responsive …

The pursuit of innovative, multifunctional, more efficient, and safer treatments is a major
challenge in preclinical nanoparticle-mediated thermotherapeutic research. Here, we report …

Technologies that enable thermal therapy treatments are now clinically viable and most
ongoing hyperthermia clinical trials in oncology incorporate chemotherapy. Given the …

Recently, the use of nanoscale materials has attracted considerable attention with the aim of
designing personalized therapeutic approaches that can enhance both spatial and temporal …

Hyperthermia, the mild elevation of temperature to 40–45° C, can induce cancer cell death
and enhance the effects of radiotherapy and chemotherapy. Due to the nature of …